Biomaterial Database

Surgical limb perfusion for extremity melanoma. 1994

G J Bowers, and E M Copeland

Department of Surgery, University of Florida Health Science Center/Jacksonville, Florida 32209.

For over 35 years, various centres throughout the world have surgically perfused extremities afflicted with various stages of melanoma. Throughout these years the true effectiveness of this invasive technique has remained controversial. Herein, an attempt has been made to critically survey this literature, with emphasis on reports from the past few years, to ascertain what role limb perfusion may play in the 1990s.

UI	MeSH Term	Description	Entries
D006979	Hyperthermia, Induced	Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs.	Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D008545	Melanoma	A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)	Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D010478	Chemotherapy, Cancer, Regional Perfusion	Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.	Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D005121	Extremities	The farthest or outermost projections of the body, such as the HAND and FOOT.	Limbs,Extremity,Limb
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970	Antineoplastic Agents	Substances that inhibit or prevent the proliferation of NEOPLASMS.	Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016896	Treatment Outcome	Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.	Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

G J Bowers, and E M Copeland

Isolated limb perfusion for recurrent melanoma of the extremity.

January 1992, Annals of plastic surgery,

G J Bowers, and E M Copeland

Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma.

June 1998, Annals of surgical oncology,

G J Bowers, and E M Copeland

A novel mouse model of isolated limb perfusion for extremity melanoma.

November 2012, The Journal of surgical research,

G J Bowers, and E M Copeland

Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.

February 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,

G J Bowers, and E M Copeland

Perfusion therapy for extremity melanoma.

September 1976, Archives of surgery (Chicago, Ill. : 1960),

G J Bowers, and E M Copeland

Isolated limb perfusion for extremity sarcoma.

November 2000, Current oncology reports,

G J Bowers, and E M Copeland

Quinacrine for extremity melanoma in a mouse model of isolated limb perfusion (ILP).

March 2015, Surgery today,

G J Bowers, and E M Copeland

Isolated limb perfusion for melanoma.

October 2008, Surgical oncology clinics of North America,